HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anneli Nilsson Selected Research

OVA-8

12/2021The human anti-CD40 agonist antibody mitazalimab (ADC-1013; JNJ-64457107) activates antigen-presenting cells, improves expansion of antigen-specific T cells, and enhances anti-tumor efficacy of a model cancer vaccine in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anneli Nilsson Research Topics

Disease

3Neoplasms (Cancer)
12/2021 - 11/2003
1Carcinoma (Carcinomatosis)
12/2021
1Lymphoma (Lymphomas)
12/2021
1Neoplasm Metastasis (Metastasis)
01/2019

Drug/Important Bio-Agent (IBA)

2mitazalimabIBA
12/2021 - 01/2019
1Granzymes (Granzyme)IBA
12/2021
1OVA-8IBA
12/2021
1AntigensIBA
12/2021
1Immunoglobulin G (IgG)IBA
12/2021
1OvalbuminIBA
12/2021
1Proteins (Proteins, Gene)FDA Link
12/2021
1Cancer VaccinesIBA
12/2021
1AntibodiesIBA
01/2019
1CytokinesIBA
01/2019
1Enterotoxins (Enterotoxin)IBA
11/2003
1EpitopesIBA
11/2003
1Monoclonal AntibodiesIBA
11/2003
1SuperantigensIBA
11/2003

Therapy/Procedure

1Immunotherapy
12/2021
1Injections
01/2019
1Therapeutics
11/2003